
Carlsmed Inc (CARL) Earnings Dates & Reports
Carlsmed Inc (CARL) Most Recent Earnings
Report DateNov 6, 2025
Period EndingQ3 2025
Est. EPS-$0.47
Actual EPS-$0.40
EarningsBeat
Carlsmed Inc (CARL) Earnings
View the latest Carlsmed Inc (CARL) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Carlsmed Inc (CARL)
Order type
Buy in
Order amount
Est. shares
0 shares
Carlsmed Inc (CARL) Earnings per Share (EPS) History
Signup for full accessBrowse free
Carlsmed Inc (CARL) Latest Earnings
The value each CARL share was expected to gain vs. the value each share gained.
Carlsmed Inc (CARL) reported its most recent earnings on Nov 6, 2025 for Q3 2025, posting earnings per share (EPS) of -$0.40. This exceeded analysts' expectations of -$0.47 by 14.89%, marking a Beat.
For comparison, Carlsmed Inc reported EPS of $0 in the same quarter last year.
The company is expected to announce its next earnings report on 02/14/2026, with analysts projecting an EPS of -$0.40.
Carlsmed Inc (CARL) Earnings History
Carlsmed Inc (CARL) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Carlsmed Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| Nov 6, 2025 | — | — | — |
| Aug 28, 2025 | — | — | — |
Carlsmed Inc (CARL) Earnings FAQs
Carlsmed Inc (CARL) last reported earnings on Nov 6, 2025 for Q3 2025, posting an EPS of -$0.40, which Beat the estimate of -$0.47 by 14.89%.
For Q3 2025, Carlsmed Inc (CARL) reported an EPS of -$0.40, exceeding analysts' estimate of -$0.47 by 14.89%.
For Q3 2025, Carlsmed Inc (CARL) Beat expectations with an actual EPS of -$0.40 vs. an estimated EPS of -$0.47.
Following the last earnings report on Nov 6, 2025, Carlsmed Inc (CARL)'s stock price moved — from — to —.
The next Carlsmed Inc (CARL) earnings call is scheduled for Feb. 14, 2026, where executives will discuss financial results and outlook.